Long non-coding RNAs in metabolic diseases : from bench to bedside
Copyright © 2021 Elsevier Ltd. All rights reserved..
Long non-coding RNAs (lncRNAs) are being widely studied for their implications in physiological and diseases contexts but their functions and therapeutic potentials in metabolic diseases are far from clarified. Here, we report a summary of current advances in lncRNAs identification, functions, role as biomarkers and therapeutic prospects in metabolic diseases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
---|---|
Enthalten in: |
Trends in endocrinology and metabolism: TEM - 32(2021), 10 vom: 19. Okt., Seite 747-749 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rey, Federica [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarkers |
---|
Anmerkungen: |
Date Completed 08.02.2022 Date Revised 08.02.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.tem.2021.05.009 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM327055642 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM327055642 | ||
003 | DE-627 | ||
005 | 20231225195930.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.tem.2021.05.009 |2 doi | |
028 | 5 | 2 | |a pubmed24n1090.xml |
035 | |a (DE-627)NLM327055642 | ||
035 | |a (NLM)34158225 | ||
035 | |a (PII)S1043-2760(21)00126-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rey, Federica |e verfasserin |4 aut | |
245 | 1 | 0 | |a Long non-coding RNAs in metabolic diseases |b from bench to bedside |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.02.2022 | ||
500 | |a Date Revised 08.02.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier Ltd. All rights reserved. | ||
520 | |a Long non-coding RNAs (lncRNAs) are being widely studied for their implications in physiological and diseases contexts but their functions and therapeutic potentials in metabolic diseases are far from clarified. Here, we report a summary of current advances in lncRNAs identification, functions, role as biomarkers and therapeutic prospects in metabolic diseases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a biomarkers | |
650 | 4 | |a clinical trials | |
650 | 4 | |a lncRNAs | |
650 | 4 | |a metabolic diseases | |
650 | 4 | |a obesity | |
650 | 4 | |a target/RNA therapy | |
650 | 7 | |a RNA, Long Noncoding |2 NLM | |
700 | 1 | |a Zuccotti, Gian Vincenzo |e verfasserin |4 aut | |
700 | 1 | |a Carelli, Stephana |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Trends in endocrinology and metabolism: TEM |d 1989 |g 32(2021), 10 vom: 19. Okt., Seite 747-749 |w (DE-627)NLM102549273 |x 1879-3061 |7 nnns |
773 | 1 | 8 | |g volume:32 |g year:2021 |g number:10 |g day:19 |g month:10 |g pages:747-749 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.tem.2021.05.009 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 32 |j 2021 |e 10 |b 19 |c 10 |h 747-749 |